Medico Remedies Limited (MEDICO) - Total Liabilities
Based on the latest financial reports, Medico Remedies Limited (MEDICO) has total liabilities worth Rs779.29 Million INR (≈ $8.43 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medico Remedies Limited - Total Liabilities Trend (2013–2026)
This chart illustrates how Medico Remedies Limited's total liabilities have evolved over time, based on quarterly financial data. See Medico Remedies Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Medico Remedies Limited Competitors by Total Liabilities
The table below lists competitors of Medico Remedies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Toplus Global Co Ltd
TWO:3522
|
Taiwan | NT$1.81 Billion |
|
Hojeon Ltd
KO:111110
|
Korea | ₩295.10 Billion |
|
Sepeda Bersama Indonesia Tbk PT
JK:BIKE
|
Indonesia | Rp248.85 Billion |
|
Blackboxstocks Inc
NASDAQ:BLBX
|
USA | $3.03 Million |
|
INFOMARK Co. Ltd
KQ:175140
|
Korea | ₩18.04 Billion |
|
Anteotech Ltd
AU:ADO
|
Australia | AU$2.82 Million |
|
CESSATECH A/S DK -20
F:8GN
|
Germany | €1.23 Million |
|
First Graphene Ltd
AU:FGR
|
Australia | AU$971.20K |
Liability Composition Analysis (2013–2026)
This chart breaks down Medico Remedies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MEDICO company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medico Remedies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medico Remedies Limited (2013–2026)
The table below shows the annual total liabilities of Medico Remedies Limited from 2013 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs779.29 Million ≈ $8.43 Million |
+35.93% |
| 2025-03-31 | Rs573.30 Million ≈ $6.20 Million |
+30.82% |
| 2024-03-31 | Rs438.24 Million ≈ $4.74 Million |
+0.50% |
| 2023-03-31 | Rs436.05 Million ≈ $4.72 Million |
+12.18% |
| 2022-03-31 | Rs388.70 Million ≈ $4.20 Million |
-9.95% |
| 2021-03-31 | Rs431.63 Million ≈ $4.67 Million |
-4.93% |
| 2020-03-31 | Rs454.03 Million ≈ $4.91 Million |
-5.55% |
| 2019-03-31 | Rs480.74 Million ≈ $5.20 Million |
+46.93% |
| 2018-03-31 | Rs327.20 Million ≈ $3.54 Million |
+2.65% |
| 2017-03-31 | Rs318.74 Million ≈ $3.45 Million |
+3.49% |
| 2016-03-31 | Rs307.99 Million ≈ $3.33 Million |
+39.17% |
| 2015-03-31 | Rs221.30 Million ≈ $2.39 Million |
-2.37% |
| 2014-03-31 | Rs226.68 Million ≈ $2.45 Million |
+70.82% |
| 2013-03-31 | Rs132.70 Million ≈ $1.44 Million |
-- |
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more